Orchard Therapeutics plc (ORTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

108 CANNON STREET LONDON, UNITED KINGDOM EC4N 6EU

Orchard Therapeutics PLC operates as biopharmaceutical company. The Company offers medical research, gene therapy, and inherited disorder treatment services. Orchard Therapeutics serves customers worldwide.

Data as of 2020-08-09
Market Cap459.085 Million Shares Outstanding97.5 Million Avg 30-day Volume530.246 Thousand
P/E Ratio Dividend Yield EPS-1.91
Price/Sales183.128 Price cash flow ratio Price free cash flow ratio-2.9
Book Value2.33 Price to Tangible Book1.74 Alpha-0.04
Short Interest Ratio % Short Interest to Float R-squared0.068151
BETA0.938451 52-week High/Low17.48 / 4.46 Stddev0.210445
View SEC Filings from ORTX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 2 1 (0.07%)
13F Filers holding this stock: 74 33 (2.16%)
Aggregate 13F shares on 03/31/2020: 67.012 Million 49.801 Million
Aggregate 13F shares on 12/31/2019: 66.379 Million 47.039 Million
Percent change: 0.95% 5.87%
Funds creating new positions: 11 7
Funds Adding to an existing position: 26 12
Funds closing out their position: 19 10
Funds reducing their position: 24 11
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ORTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ORTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FMR LLC

  • 10% Owner
  • SEE REMARK 1
7,328,586 2020-08-07 2

ROWLAND CHARLES A JR

  • Director
70,500 2020-07-29 2

GLAXOSMITHKLINE PLC

  • 10% Owner
4,626,389 2020-07-24 1

GERAGHTY JAMES A

  • Director
91,253 2020-07-01 2

ALTSCHULER STEVEN

  • Director
24,604 2020-06-29 3

DUNOYER MARC

  • Director
0 2020-06-17 2

CURNUTTE JOHN T

  • Director
0 2020-06-17 2

BECK JOANNE T.

  • Director
0 2020-06-17 2

SECOR ALICIA

  • Director
0 2020-06-17 2

THOMAS FRANK E SEE REMARKS

  • Officer
25,120 2020-06-11 4

GASPAR BOBBY CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-04-01 4

ELLIS JON

  • Director
0 2020-01-01 1

ROTHERA MARK SEE REMARKS

  • Officer
  • Director
103,796 2020-01-01 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

SECOR ALICIA - Director

2020-06-17 A 35,000 a 35,000 0.00 direct

BECK JOANNE T. - Director

2020-06-17 A 35,000 a 35,000 0.00 direct

ROWLAND CHARLES A JR - Director

2020-06-17 A 35,000 a 35,000 0.00 direct

CURNUTTE JOHN T - Director

2020-06-17 A 35,000 a 35,000 0.00 direct

GERAGHTY JAMES A - Director

2020-06-17 A 35,000 a 35,000 0.00 direct

DUNOYER MARC - Director

2020-06-17 A 35,000 a 35,000 0.00 direct

ALTSCHULER STEVEN - Director

2020-06-17 A 35,000 a 35,000 0.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments